Keld Flintholm Jørgensen
Director/Board Member chez SCANDION ONCOLOGY A/S
Profil
Keld Flintholm Jørgensen is currently an Independent Director at Scandion Oncology A since 2022 and a Senior VP & Head-Business Development at H.
Lundbeck A since 2019.
Previously, he worked as a Director-Strategic Partnering at Roche Pharma (Schweiz) AG.
He has an undergraduate and graduate degree from Copenhagen Business School.
Postes actifs de Keld Flintholm Jørgensen
| Sociétés | Poste | Début |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | 04/04/2019 |
| SCANDION ONCOLOGY A/S | Director/Board Member | 01/04/2022 |
Anciens postes connus de Keld Flintholm Jørgensen
| Sociétés | Poste | Fin |
|---|---|---|
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Corporate Officer/Principal | - |
Formation de Keld Flintholm Jørgensen
| Copenhagen Business School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Entreprise privées | 1 |
|---|---|
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Distribution Services |
